Ui Okada
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 10%
- Escherichia coli research studies
Papers in
- Oncology 8
- Drug Transport and Resistance Mechanisms 8
-
- Antibiotic Resistance in Bacteria 8
- Co-authors
- Satoshi Murakami (10 shared papers)Hendrik W. van Veen (3 shared papers)Arthur Neuberger (2 shared papers)Eiki Yamashita (6 shared papers)Ben F. Luisi (1 shared paper)Dijun Du (1 shared paper)James N. Blaza (1 shared paper)Sjors H. W. Scheres (1 shared paper)
- Journals
- Nature Communications (3 papers)FEBS Letters (2 papers)Microbiology (1 paper)Journal of Biological Chemistry (1 paper)Journal of Molecular Biology (1 paper)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Ui Okada
13 papers receiving 361 citations
Peers
Comparison fields: 5 of 58
- Molecular Medicine 179
- Endocrinology 49
- Genetics 120
- Pollution 41
- Structural Biology 5
Countries citing papers authored by Ui Okada
This map shows the geographic impact of Ui Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ui Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ui Okada more than expected).
Fields of papers citing papers by Ui Okada
This network shows the impact of papers produced by Ui Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ui Okada. The network helps show where Ui Okada may publish in the future.
Co-authors
The 25 scholars most cited alongside Ui Okada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 145 | |
| 2 | 2017 | 76 | |
| 3 | 2021 | 47 | |
| 4 | 2005 | 34 | |
| 5 | 2013 | 15 | |
| 6 | 2022 | 14 | |
| 7 | 2008 | 12 | |
| 8 | 2020 | 7 | |
| 9 | 2006 | 6 | |
| 10 | 2014 | 6 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2018 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 |
About Ui Okada
Ui Okada is a scholar working on Oncology, Molecular Medicine, Genetics, Molecular Biology and Pharmacology, having authored 15 papers that have together received 371 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Bacterial Genetics and Biotechnology (8 papers), Antibiotic Resistance in Bacteria (8 papers), Microbial Natural Products and Biosynthesis (4 papers), RNA and protein synthesis mechanisms (3 papers), Cancer therapeutics and mechanisms (2 papers), Burkholderia infections and melioidosis (1 paper) and Pediatric Hepatobiliary Diseases and Treatments (1 paper). The work is most often cited by research in Molecular Medicine (179 citations), Endocrinology (49 citations), Genetics (120 citations), Pollution (41 citations) and Structural Biology (5 citations). Ui Okada has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Satoshi Murakami, Hendrik W. van Veen, Arthur Neuberger, Eiki Yamashita, Ben F. Luisi, Dijun Du, James N. Blaza, Sjors H. W. Scheres, Xiao‐chen Bai and Ulrich Zachariae. Their work appears in journals such as Nature Communications, FEBS Letters, Microbiology, Journal of Biological Chemistry and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.